Table 2.
Unmatched cohort (n = 105) | |||
Variables | RPSS group ( n = 26 ) | EC group ( n = 79 ) | p value |
Surgical outcomes | |||
Surgical technique | |||
Sigmoidectomy/AR/LAR/SLAR | 4/8/7/7 | 6/17/30/26 | 0.54 |
Ileostomy N (%) | 9 (35) | 29 (37) | 1.0 |
Total operation times | |||
All surgical techniquesa min | 294 (131) | 340 (193) | 0.19 |
Sigmoidectomy, ARa min | 256 (90) | 242 (100) | 1.0 |
LARa min | 326 (213) | 373 (113) | 0.62 |
SLARa min | 361 (154) | 517 (280) | 0.064 |
Blood lossb mL | 5 (9.5) | 19 (40) | 0.014 |
Length of umbilical incisionb mm | 29 (0.57) | 31 (0.63) | 0.047 |
Leak test positive N (%) | 0 (0) | 0 (0) | |
Oncologic clearance | |||
Number of lymph nodes harvesteda | 15 (8.5) | 17 (13) | 0.34 |
Lateral lymph node dissection N (%) | 3 (12) | 11 (14) | 1.0 |
CRM positive N (%) | 0 (0) | 1 (1.3) | 1.0 |
pStaging | |||
0/I/II/III/IV | 0/10/7/7/2 | 1/27/24/23/4 | 0.94 |
Matched cohort after a 1:1 Propensity score matching (n = 46) | |||
Variables | RPSS group ( n = 23 ) | EC group ( n = 23 ) | p value |
Surgical outcomes | |||
Surgical technique | |||
Sigmoidectomy/AR/LAR/SLAR | 4/7/6/6 | 4/6/5/8 | 0.93 |
Ileostomy N (%) | 7 (30) | 9 (39) | 0.54 |
Total operation times | |||
All surgical techniquesa min | 293 (116) | 337 (279) | 0.36 |
Sigmoidectomy, ARa min | 268 (96) | 252 (106) | 0.86 |
LARa min | 279 (143) | 334 (180) | 0.58 |
SLARa min | 401 (210) | 649 (309) | 0.045 |
Blood lossb mL | 5.3 (10) | 23 (36) | 0.038 |
Length of umbilical incisionb mm | 30 (0.56) | 32 (0.53) | 0.15 |
Leak test positive N (%) | 0 (0) | 0 (0) | |
Oncologic clearance | |||
Number of lymph nodes harvesteda | 16 (9) | 19 (18) | 0.21 |
Lateral lymph node dissection N (%) | 2 (8.7) | 6 (26) | 0.11 |
CRM positive N (%) | 0 (0) | 0 (0) | |
pStaging | |||
0/I/II/III/IV | 0/9/6/7/1 | 0/8/9/6/0 | 0.63 |
AR Anterior resection, LAR Low anterior resection, SLAR Super low anterior resection, CRM Circumferential resection margin
aValues are median (IQR)
bValues are mean (SD)